水产养殖疫苗市场规模、份额和成长分析（按产品、给药途径、应用和地区划分）—产业预测，2026-2033年

预计到 2024 年，全球水产养殖疫苗市场规模将达到 2.3091 亿美元，从 2025 年的 2.4846 亿美元增长到 2033 年的 4.4643 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.6%。

养殖物种细菌和病毒性行为感染的增加迫使生产者采取疫苗接种策略，推动了全球水产养殖疫苗市场的显着成长。针对各种病毒性疾病的创新疫苗的研发和推广对于提升市场收入至关重要。随着产业的演变，疫苗类型已从传统的活病毒疫苗显着转向DNA疫苗和重组疫苗。对新型疫苗研发投入的不断增加也推动了这一成长。此外，水产养殖产量的成长和消费者对水产品日益增长的需求进一步刺激了对有效疫苗解决方案的需求。水产养殖业和更广泛的动物健康领域的许多主要企业正在重新分配资源以满足这些关键需求，这充分体现了该市场的活力。

全球水产养殖疫苗市场驱动因素

由于各种疾病爆发导致鱼类死亡率上升，全球水产养殖疫苗市场呈现成长态势，迫切需要有效的疫苗解决方案。全球对鱼类作为动物性蛋白质来源的需求不断增长，以及各国政府对水产养殖疫苗倡议的大力支持，进一步推动了这个市场扩张。此外，成熟市场和新兴市场对疫苗的日益普及预计也将推动市场动态。养殖鱼类国际贸易的不断增长也将对市场发展起到关键作用，使水产养殖疫苗成为全球永续水产养殖实践不可或缺的一部分。

限制全球水产养殖疫苗市场的因素

开发符合严格环境和监管标准的高性价比佐剂和抗原，会对水产养殖疫苗的市场动态重大影响。遵守这些基本准则通常会增加生产成本和复杂性，最终阻碍该行业的疫苗销售。因此，製造商被迫在确保产品功效和满足合规要求之间寻求平衡，而这项挑战可能会限制水产养殖疫苗的市场份额。这些因素综合起来，可能会阻碍产业成长，并影响水产养殖疫苗市场的供给与需求双方。

全球水产养殖疫苗市场趋势

由于技术进步、人们对水产养殖疾病的认识不断提高以及公私合营在研发领域的加强，全球水产养殖疫苗市场正呈现显着的成长趋势。诊断和治疗技术的创新，尤其是在发展中地区，以及医疗费用支出的不断增长，预计将推动市场成长。此外，产业内策略联盟和合作的日益增多，以及对通用感染疾病的日益关注，也进一步刺激了对水产养殖疫苗的需求。这些因素共同推动了整体市场成长，为食品生产产业这一关键领域的持续成长铺平了道路。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究

全球水产养殖疫苗市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 减毒活病毒疫苗
• 灭活疫苗
• 次单位疫苗
• DNA疫苗
• 重组疫苗

全球水产养殖疫苗市场规模（按给药途径和复合年增长率划分）（2026-2033 年）

• 口服
• 注射
• 浸泡/喷洒

全球水产养殖疫苗市场规模（按应用和复合年增长率划分）（2026-2033 年）

• 细菌
• 病毒性的
• 寄生虫
• 其他的

全球水产养殖疫苗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Elanco Animal Health（USA）
• Hipra（Spain）
• Ceva Sante Animale（France）
• Vaxxinova（Netherlands）
• AquaBounty Technologies（USA）
• Benchmark Holdings plc（UK）
• Pharmaq AS（Norway）
• Phibro Animal Health Corporation（USA）
• KBNP（South Korea）
• Nisseiken Co., Ltd.（Japan）
• Kyoto Biken Laboratories, Inc.（Japan）
• Cavac（China）
• VETERQUIMICA SA（Spain）
• CSL Limited（Australia）
• Emergent BioSolutions, Inc.（USA）
• Johnson & Johnson（USA）
• AstraZeneca plc（UK）
• Sanofi SA（France）

结论与建议

Global Aquaculture Vaccine Market size was valued at USD 230.91 Million in 2024 and is poised to grow from USD 248.46 Million in 2025 to USD 446.43 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global aquaculture vaccine market is poised for significant growth driven by escalating bacterial and viral infections among aquaculture species, compelling producers to adopt vaccination strategies. The development and introduction of innovative vaccines targeting various viral diseases are crucial for enhancing market revenue. A notable shift is occurring, moving from traditional live attenuated vaccines towards DNA and recombinant vaccines, reflecting industry evolution. Increased investment in research and development of novel vaccines further supports this expansion. Additionally, rising aquaculture production and a growing consumer preference for seafood products heighten the demand for effective vaccination solutions. Numerous key players from both aquaculture and broader animal health sectors are reallocating resources to meet these essential needs, showcasing the dynamic nature of this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aquaculture Vaccine Market Segments Analysis

Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is poised for growth due to rising fish mortality rates attributed to various disease outbreaks, which create an urgent demand for effective vaccination solutions. The increasing global appetite for fish as a source of animal protein, coupled with substantial government backing for vaccination initiatives in aquaculture, further fuels this expansion. Additionally, a rising adoption of vaccines in both established and emerging markets is expected to enhance market dynamics. Increased international trade of aquaculture species will also play a crucial role in driving market advancements, positioning aquaculture vaccines as essential in sustainable fish farming practices worldwide.

Restraints in the Global Aquaculture Vaccine Market

The development of cost-effective adjuvants and antigens that comply with stringent environmental and regulatory standards can significantly influence the market dynamics of aquaculture vaccines. This adherence to necessary guidelines often leads to increased production costs and complexities, ultimately hindering vaccination sales within the sector. Consequently, these challenges may restrict the market share for aquaculture vaccines, as manufacturers must navigate the balance between ensuring product efficacy and meeting compliance demands. The combination of these factors can create obstacles for industry growth, impacting both supply and demand in the aquaculture vaccine market.

Market Trends of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is experiencing a significant upward trend driven by advancements in technology, heightened awareness of aquaculture diseases, and increased public-private partnerships aimed at research and development. Innovations in diagnostics and therapeutics, particularly in developing regions, alongside rising healthcare expenditure, are poised to propel market growth. Moreover, the proliferation of strategic alliances and collaborations within the industry, combined with the escalating concerns over zoonotic diseases, further amplify the demand for aquaculture vaccines. The overall market is expected to thrive as these factors converge, paving the way for sustained growth in this vital sector of the food production industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Aquaculture Vaccine Market Size by Product & CAGR (2026-2033)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Aquaculture Vaccine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injected
• Immersion & Spray

Global Aquaculture Vaccine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacterial
• Viral
• Parasitic
• Others

Global Aquaculture Vaccine Market Size & CAGR (2026-2033)

• North America (Product, Route of Administration, Application)
  • US
  • Canada
• Europe (Product, Route of Administration, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AquaBounty Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaq AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBNP (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nisseiken Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Biken Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cavac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VETERQUIMICA SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations